Medpace Holdings, Inc. (MEDP) 은(는) 상장 기업입니다 헬스케어 섹터의 Medical - Diagnostics & Research 산업에서 운영. 본사 소재지는 Cincinnati, OH, 미국. 현재 CEO는 August James Troendle.
MEDP 을(를) 보유 IPO 날짜 2016-08-11, 5,900 명의 정규직 직원, 에 상장 NASDAQ Global Select, 시가총액 $14.85B.
Medpace Holdings, Inc. is a clinical research organization that provides comprehensive drug and medical device development services to pharmaceutical, biotechnology, and medical device companies across North America, Europe, and Asia. The company supports the entire clinical development lifecycle from Phase I through Phase IV trials, offering specialized services including clinical monitoring, regulatory affairs, data management, pharmacovigilance, and post-marketing support across multiple therapeutic areas. Medpace also provides specialized laboratory services including bio-analytical testing, clinical human pharmacology, imaging services, and electrocardiography support. Founded in 1992 and headquartered in Cincinnati, Ohio, the company serves as a trusted partner in advancing new drug and device candidates toward regulatory approval.
